More on BOCX
Financials
News
Click line-items for a historical chart and %
| Revenue | 7.93K |
| Amortization of patents (Note 3) | 1.23K |
| General and administrative (Note5 (a) & 8) | 155.13K |
| Impairment of patents | 325.76K |
| Professional and consulting fees | 40.69K |
| Research and development (Note 5(a)) | 103.91K |
| Total Operating Expenses | 626.72K |
| Loss From Operations | -618.79K |
| Accretion of discounts on debt | -23.77K |
| Amortization of debt issue costs | -9.62K |
| Gain (loss) on derivative | |
| Loss on extinguishments of convertible debt | 0 |
| Gain on sale of equity investment securities | 0 |
| Gain on settlement of accounts payable | 0 |
| Interest expense | -57.7K |
| Interest income | 0 |
| Total Other Income (Expense) | -127.25K |
| Net Loss and Comprehensive loss for the Period | -746.03K |
| Net Loss Per Share - Basic and Diluted | 0 |
| Weighted Average Shares Outstanding | 289.52M |
